Covid-19: Export curbs on imported API drugs under review

The commerce and industry ministry is studying a proposal to allow exports of drugs from active pharmaceutical ingredients (API) which have been imported under an advance license wherein duty-free imports are bound to certain export obligations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2TZb57S
via Latest News of India